A federal appeals court affirmed a lower court’s $22 million verdict against Cordis Corp., the stent-making arm of Johnson & Johnson (NYSE:JNJ), in a patent infringement case brought by Spectranetics Corp. (NSDQ:SPNC), but sent the case back for consideration of further damages.
Patent Infringement
Appeals court backs BSX over Cordis | Legal Roundup
Appeals court backs Boston Scientific in patent spat with J&J’s Cordis Corp.
Patent infringement plaintiffs rejoice: Appeals court raises the bar for inequitable conduct | Legal News
Medsquire sues Quest, HP, 12 others in HIT patent spat
Medsquire LLC slapped 14 companies, including some of corporate America’s biggest names, with a patent infringement lawsuit covering electronic medical records systems.
Boston Scientific sues rep to claw back $200,000 overpayment | Legal Roundup
Boston Scientific (NYSE:BSX) is suing one of its sales reps in Arizona, seeking to claw back about $200,000 it says it overpaid Michael McCormick last year.
The lawsuit, filed in the U.S. District Court for Minnesota, claims that McCormick tried to resign after the Natick, Mass.-based company approached him with a new employment contract that would have accounted for the snafu.
DePuy Pinnacle hip implant lawsuits consolidated in Texas | Legal Roundup
A group of at least 57 product liability lawsuits filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over one of its metal-on-metal hip implants were consolidated in the U.S. District Court for Northern Texas.
Analogic founder Gordon sues over NeuroLogica buyout | Legal Roundup
Bernard Gordon, who founded medical imaging giant Analogic Corp. (NSDQ:ALOG) in 1964, is accusing the company of deliberately interfering with acquisitions of his new firm, NeuroLogica Corp.
In a lawsuit filed in the U.S. District Court for Massachusetts, NeuroLogica and co-plaintiffs Gordon and two other NeuroLogica executives accuse Analogic of seeking to prevent another, un-named company from acquiring NeuroLogica in a bid to force a below-market buyout in its own favor.
Occlutech claims German victory in latest patent fight round with St. Jude and AGA
Occlutech GmbH won another round in its ongoing patent dispute with St. Jude Medical Inc. (NYSE:STJ) acquisition AGA Medical.
The German Supreme Court (BGH) in Karlsruhe ruled that it does not see any basis for AGA Medical’s claim that Occlutech’s atrial septal defects (ASD) and patent foramen ovale (PFO) occlusion devices violate the company’s patents.